Nitroxyl, redox switches, cardiac myofilaments, and heart failure: A prequel to novel therapeutics?

Circulation Research

Volumn 111, Issue 8, 2012, Pages 954-956

  Ge, Ying ^a   Moss, Richard L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

contractility; disulfide; heart failure; mass spectrometry; nitroxyl

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISTAROXIME; NITROXYL; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG MECHANISM; HEART FAILURE; HEART FUNCTION; MYOFILAMENT; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISULFIDES; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOFIBRILS; NITROGEN OXIDES;

EID: 84866904001     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.278416     Document Type: Review

References (22)

1. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature. 2008;451:919-928. (Pubitemid 351301747)
2. Hasenfuss G, Teerlink Jr. Cardiac inotropes: current agents and future directions. Eur Heart J. 2011;32:1838-1845.
3. Gao WD, Murray CI, Tian Y, Zhong X, Dumond JF, Shen X, Stanley BA, Foster DB, Wink DA, King SB, Van Eyk JE, Paolocci N. Nitroxyl mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res. 2012;111:1002-1011.
4. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK. Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci. 2008;29:601-608.
5. Miranda KM. The chemistry of nitroxyl (hno) and implications in biology. Coordination Chemistry Reviews. 2005;249:433-455. (Pubitemid 40093751)
6. Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, Fukuto JM. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther. 2007;113:442-458.
7. Switzer CH, Flores-Santana W, Mancardi D, Donzelli S, Basudhar D, Ridnour LA, Miranda KM, Fukuto JM, Paolocci N, Wink DA. The emergence of nitroxyl (HNO) as a pharmacological agent. Biochim Biophys Acta. 2009;1787:835-840.
8. Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N. Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function. Antioxid Redox Signal. 2011;14:1687-1698.
9. Bartberger MD, Fukuto JM, Houk KN. On the acidity and reactivity of HNO in aqueous solution and biological systems. Proc Natl Acad Sci USA. 2001;98:2194-2198. (Pubitemid 32209458)
10. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA. 2001;98:10463-10468. (Pubitemid 32803042)
11. Paolocci N, Katori T, Champion HC, St John ME, Miranda KM, Fukuto JM, Wink DA, Kass DA. Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci USA. 2003;100:5537-5542. (Pubitemid 36542740)
12. Tocchetti CG, Wang W, Froehlich JP, et al. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res. 2007;100:96-104. (Pubitemid 46066777)
13. Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, Gao WD. Nitroxyl increases force development in rat cardiac muscle. J Physiol (Lond). 2007;580:951-960. (Pubitemid 46909044)
14. Yuan C, Solaro RJ. Myofilament proteins: From cardiac disorders to proteomic changes. Proteomics Clin Appl. 2008;2:788-799. (Pubitemid 351943761)
15. Jin W, Brown AT, Murphy AM. Cardiac myofilaments: from proteome to pathophysiology. Proteomics Clin Appl. 2008;2:800-810. (Pubitemid 351943762)
16. Zhang H, Ge Y. Comprehensive analysis of protein modifications by top-down mass spectrometry. Circ Cardiovasc Genet. 2011;4:711.
17. Ge Y, Rybakova IN, Xu Q, Moss RL. Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state. Proc Natl Acad Sci USA. 2009;106:12658-12663.
18. Wouters MA, Fan SW, Haworth NL. Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid Redox Signal. 2010;12:53-91.
19. Gorman JJ, Wallis TP, Pitt JJ. Protein disulfide bond determination by mass spectrometry. Mass Spectrom Rev. 2002;21:183-216.
20. Peng Y, Chen X, Sato T, Rankin SA, Tsuji RF, Ge Y. Purification and high-resolution top-down mass spectrometric characterization of human salivary a-amylase. Anal Chem. 2012;84:3339-3346.
21. Sha X, Isbell TS, Patel RP, Day CS, King SB. Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO). J Am Chem Soc. 2006;128:9687-9692. (Pubitemid 44147951)
22. Moss RL, Razumova M, Fitzsimons DP. Myosin crossbridge activation of cardiac thin filaments: implications for myocardial function in health and disease. Circ Res. 2004;94:1290-1300. (Pubitemid 38724474)